scholarly article | Q13442814 |
P50 | author | Felix Zintl | Q15453728 |
Klaus-Michael Debatin | Q18022197 | ||
Bernd Gruhn | Q89749384 | ||
Daniel Steinbach | Q110990457 | ||
P2093 | author name string | Roland Zell | |
James F Beck | |||
Selim Corbacioglu | |||
Nadine Pfaffendorf | |||
Juliane Intek | |||
P433 | issue | 12 | |
P304 | page(s) | 1571-1577 | |
P577 | publication date | 2009-10-01 | |
P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
P1476 | title | Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children | |
P478 | volume | 15 |
Q90374351 | A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms |
Q27021123 | Advances in predicting acute GVHD |
Q54636018 | Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population. |
Q28248522 | Association between NOD2 single nucleotide polymorphisms and Grade III-IV acute graft-versus-host disease: A meta-analysis |
Q28075204 | Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives |
Q35224947 | Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. |
Q27026616 | Evaluation of published single nucleotide polymorphisms associated with acute GVHD |
Q39263959 | From genetic single candidate gene studies to complex genomics of GvHD. |
Q37810124 | Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation. |
Q26824540 | Graft-versus-host disease biomarkers: omics and personalized medicine |
Q38539817 | IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. |
Q35564082 | Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation. |
Q35084400 | Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD |
Q33839876 | Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation |
Q38057238 | NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome |
Q38502469 | Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome? |
Q38132090 | Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses |
Q37887810 | Role of gut microbiota in graft-versus-host disease |
Q38129337 | Role of non-HLA gene polymorphisms in graft-versus-host disease. |
Q37973866 | The IL-17 differentiation pathway and its role in transplant outcome |
Q84561203 | Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors |
Q38712496 | Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease |
Search more.